I agree that there was misguided COVID investment but their technology will support post-diagnosis evaluation of COVID - that said their market is big enough without COVID that COVID was actually a hindrance to operational activities.
Relatively low volumes of trading still going on and it looks like there are some tightly held parcels still (would love someone with technical background to provide some analysis).
Ultimately, as we have always thought we need to see trials convert to paid contracts and the timeline for this will be over the course of this year and next.
As COVID starts to be controlled it should allow them to continue conversations with hospitals etc.
I agree that there was misguided COVID investment but their...
-
- There are more pages in this discussion • 2,249 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.5¢ |
Change
-0.015(2.54%) |
Mkt cap ! $225.0M | |||
| Open | High | Low | Value | Volume |
| 59.0¢ | 60.5¢ | 57.5¢ | $750.6K | 1.266M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 43375 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 24198 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |